Failed IVF Multiple Times in Mainland? How About Hong Kong? Reproductive Doctor Analyzes Suitable Conditions & Process

Opening of the main text: Real consultation scenario

"Doctor, I've had three IVF cycles in Mainland, two with no implantation and one biochemical pregnancy. My AMH is 1.2, and I'm 38 years old. I'm wondering if going to Hong Kong would lead to a different outcome?" — This is an increasingly common type of consultation in outpatient clinics.

Whether it is suitable to go to Hong Kong after multiple failed IVF attempts in Mainland needs to be comprehensively assessed based on the cause of failure, age, ovarian reserve, uterine conditions, and the suitability of Hong Kong medical facilities. The following analysis is provided from a reproductive medicine perspective.

1. Multiple IVF Failures in Mainland: Common Causes and Evaluation

Recurrent implantation failure (RIF) is clinically defined as ≥3 embryo transfers or cumulative transfer of ≥4 good-quality embryos without achieving clinical pregnancy. Causes can be categorized as follows:

• Embryo factors: Chromosomal aneuploidy is the most common cause of implantation failure, especially in women aged ≥35, where the rate of embryonic aneuploidy increases significantly.
• Uterine factors: Intrauterine adhesions, endometrial polyps, uterine fibroids (submucosal or intramural), adenomyosis, decreased endometrial receptivity, etc.
• Immune factors: Abnormal natural killer (NK) cell activity, antiphospholipid antibody syndrome, thyroid autoantibodies, etc.
• Endocrine factors: Thyroid dysfunction, hyperprolactinemia, luteal phase deficiency, insulin resistance, etc.
• Male factors: Elevated sperm DNA fragmentation index (DFI), affecting embryo developmental potential.
• Unexplained: In about 20%-30% of RIF patients, the cause cannot be identified despite systematic evaluation.

2. Characteristics of Assisted Reproduction in Hong Kong: Key Differences from Mainland

Assisted reproductive technology in Hong Kong has its own characteristics in laboratory standards, PGT application, medication protocols, etc., but it is not a "universal solution." The following is an objective comparison from several dimensions:

From the table above, it can be seen that Hong Kong has characteristics in certain areas (e.g., PGT accessibility, laboratory quality control), but it is not superior to Mainland in all dimensions. The key to choosing Hong Kong lies in: whether the cause of your failure is precisely the issue that the Hong Kong medical system can specifically address.

3. When is it Suitable to Go to Hong Kong?

Based on clinical experience, the following situations may benefit from new solutions in Hong Kong:

• Recurrent implantation failure with suspected embryonic chromosomal abnormalities: Age ≥38, previous transferred embryos all failed to implant, or miscarriage tissue indicated chromosomal abnormalities; PGT-A screening may be considered.
• Need for more precise laboratory evaluation: For example, elevated sperm DNA fragmentation index, delayed embryo development, low blastocyst formation rate; some Hong Kong centers offer more in-depth embryo kinetic analysis.
• Multiple protocol attempts in Mainland have failed, seeking a second opinion: Hong Kong reproductive specialists are often internationally trained and may propose different stimulation or transfer strategies.
• Need for specific immunological evaluation and management: Some Hong Kong centers offer more comprehensive immune screening (e.g., NK cell cytotoxicity, Th1/Th2 ratio).

4. When is it Not Suitable to Go to Hong Kong?

• Systematic failure cause analysis not yet completed: If basic tests like hysteroscopy, karyotyping, or thyroid function haven't been done, blindly changing locations is not recommended.
• Limited financial resources: A complete IVF cycle in Hong Kong costs approximately HKD 80,000-150,000 (excluding PGT), which is 2-3 times that in Mainland, and most costs are out-of-pocket.
• Physical condition unsuitable for long-distance travel: Conditions like uncontrolled hypertension, diabetes, or thrombophilia increase risks with long travel and异地 medical care.
• Unrealistic expectations of success: The live birth rate in Hong Kong is not 100% and is also constrained by factors like age, ovarian reserve, and uterine conditions.

5. Specific Process: From Consultation to Transfer

5.1 Preliminary Preparation (1-2 months)

• Organize all previous records: Including stimulation protocols, medication records, number of eggs retrieved, embryo grading, transfer records, and miscarriage tissue chromosome results (if available).
• Complete supplementary tests: Hong Kong doctors usually require AMH, FSH, LH, E2, thyroid function, hysteroscopy report, and male semen analysis + DNA fragmentation index within the last 3 months.
• Document preparation: Mainland Travel Permit for Hong Kong and Macao + valid endorsement (multiple entries recommended); some hospitals require original marriage certificate and translation.

5.2 First Visit to Hong Kong for Consultation (3-5 days)

• Communicate in person with the reproductive specialist and submit all test reports.
• The doctor will advise whether some tests need to be repeated in Hong Kong (e.g., hysteroscopy, immune screening).
• Determine the stimulation protocol and approximate timeline.

5.3 Ovarian Stimulation and Egg Retrieval (approx. 12-16 days)

• Stimulation starts on day 2-3 of menstruation, with hormone + ultrasound monitoring every 1-2 days.
• Egg retrieval is usually performed as an outpatient procedure under intravenous sedation; patients can be discharged after 2-4 hours of observation.
• After retrieval, patients need to stay in Hong Kong until embryo culture results are available (approx. 5-6 days).

5.4 Embryo Culture and PGT (if needed)

• Blastocyst culture is performed on days 5-6 after retrieval, along with biopsy.
• PGT-A results take 10-14 working days; during this time, patients can return to Mainland and wait.

5.5 Transfer and Luteal Support

• Determine the transfer window (natural cycle or hormone replacement cycle).
• The transfer procedure is simple and quick; patients rest in bed for 30 minutes afterward.
• Continue luteal support (injections or oral) after transfer; blood pregnancy test on day 12-14.

6. Most Easily Overlooked Details

• Validity of test reports: Most Hong Kong centers require karyotyping and hysteroscopy reports within 1 year, and infectious disease screening within 3-6 months. Expired reports need to be redone.
• Medication continuity: Stimulation medications must be brought from Hong Kong or delivered by Hong Kong pharmacies; Mainland cannot directly prescribe medications on Hong Kong prescriptions.
• Language communication: Although most Hong Kong doctors can communicate in Mandarin, some nurses and staff primarily speak Cantonese or English; it is advisable to confirm language support in advance.
• Accommodation arrangement: During stimulation, frequent clinic visits for monitoring are required; choose accommodation within a 30-minute drive from the fertility center.
• Medical record mutual recognition: Hong Kong hospitals generally accept test reports from Mainland tertiary hospitals, but some special tests (e.g., immunological markers) may need to be repeated.

7. Factors Affecting Cost

The cost of IVF in Hong Kong consists of several parts. The following are approximate ranges (HKD):

• Consultation fee: 800-1500 per visit
• Basic tests: 5000-15000 (depending on items)
• Stimulation medications: 15000-30000
• Egg retrieval + embryo culture: 40000-60000
• PGT-A screening: 20000-40000 (charged per embryo)
• Transfer procedure: 15000-25000
• Luteal support medications: 3000-8000

A complete cycle without PGT costs approximately HKD 80,000-120,000; with PGT, it is about HKD 120,000-180,000. If the first cycle is unsuccessful, subsequent cycles may cost less (some tests do not need to be repeated).

8. Case Scenario Analysis

Scenario 1: A 39-year-old woman, AMH 0.9, had 2 failed transfers in Mainland without PGT. After coming to Hong Kong, PGT-A screening was performed. Only 1 out of 5 blastocysts was chromosomally normal. Transfer resulted in successful pregnancy. → Key point: Age + recurrent implantation failure; PGT screening identified the root cause.

Scenario 2: A 35-year-old woman with 3 failed transfers, normal hysteroscopy, but immune tests showed significantly elevated NK cell activity. After receiving immunomodulatory therapy (IVIG + intralipid) in Hong Kong, subsequent transfer was successful. → Key point: Intervention targeting immune factors.

Scenario 3: A 42-year-old woman, AMH 0.4, had 2 egg retrievals in Mainland that yielded no transferable embryos. A Hong Kong doctor used a mild stimulation protocol + letrozole, retrieved 2 eggs, formed 1 blastocyst, PGT normal, and transfer was successful. → Key point: Individualized stimulation protocol may be more effective for poor ovarian responders.

9. Observations from Practitioners

After extensive contact with patients referred from Mainland, several common phenomena have been observed:

• Most patients had not completed a systematic RIF evaluation in Mainland; after coming to Hong Kong, they discovered that some basic tests (e.g., hysteroscopy, sperm DNA fragmentation index) had never been done.
• Some patients have a "superstitious" belief about Hong Kong IVF, thinking that success is guaranteed just by going there. In reality, the overall live birth rate in Hong Kong is also significantly affected by age: about 45%-50% for under 35, 25%-30% for 38-40, and 10%-15% for over 42.
• Financial cost is one of the biggest constraints. Many patients opt for only one cycle due to cost pressure; if it fails, the psychological and financial blow can be substantial.
• Hong Kong doctors tend to recommend elective single embryo transfer (eSET) to reduce the risk of multiple pregnancies, which may require adjustment for patients hoping to "transfer two embryos to increase success rate."

10. Doctor's Recommendations

If you are considering going to Hong Kong after multiple failed IVF attempts in Mainland, the following steps may serve as a reference:

1. Complete a systematic RIF evaluation locally first: Including hysteroscopy, karyotyping for both partners, thyroid function, coagulation function, initial immune screening (antiphospholipid antibodies, NK cells, etc.), and sperm DNA fragmentation index.
2. Have a remote consultation with all reports: Most Hong Kong fertility centers offer video consultations; you can communicate online first to determine if a trip to Hong Kong is necessary.
3. Define your goal: Is it for PGT screening? Seeking a different stimulation protocol? Or undergoing immunotherapy? The clearer the goal, the higher the probability of success.
4. Make a financial plan: Reserve funds for at least 2 cycles to avoid stopping midway due to financial issues.
5. Manage expectations: Hong Kong is not a place that "guarantees success," but a place that "offers different perspectives and methods." The final outcome is still governed by medical principles.

Risk reminder: All assisted reproductive treatments carry risks of failure, including but not limited to no response to stimulation, no eggs retrieved, fertilization failure, embryo developmental arrest, no pregnancy after transfer, miscarriage, ectopic pregnancy, etc. When choosing a treatment location, comprehensively evaluate medical conditions, financial capacity, time costs, and psychological resilience, and make a decision after thorough communication with your reproductive specialist.